Company News 08 Apr 2024 Quarterly Report – Period To 31 March 2024 Orthocell has today published its Quarterly Report for the period ended 31 March 2024. Orthocell
Media 26 Mar 2024 Proactive Interview with Paul Anderson Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation… Orthocell
Company News 25 Mar 2024 Orthocell Successfully Completes Surgeries for Remplir™ US Market Authorisation Orthocell has announced that it has successfully completed the first stage of the Remplir™ US 510(k) market authorisation nerve repair… Orthocell
Media, Video 23 Feb 2024 Proactive | Interview with CEO Paul Anderson Orthocell CEO Paul Anderson spoke with Proactive about the Company's recent strategic placement of $3.5 million, adding prominent investors to the… Orthocell
Media 22 Feb 2024 The West Australian | Chris Ellison, Rod Jones and the McCuskers jump into Orthocell Orthocell's Company-led strategic placement has been reported in The West Australian newspaper today, in an article by Senior Business Report… Orthocell
Company News 22 Feb 2024 Orthocell Completes $3.5M Strategic Placement Orthocell has today announced that it has completed a Company-led Strategic Placement to raise $3.5 million. Orthocell
Company News 13 Feb 2024 Orthocell submits Singapore Regulatory Application for Remplir™ Orthocell has today announced that the Company has submitted a regulatory application to the Health Services Authority of Singapore for… Orthocell
Company News 15 Jan 2024 The Hon Kim Beazley AC Joins Orthocell Board Orthocell has appointed Australia’s former US ambassador and Governor of Western Australia, The Hon Kim Beazley AC, as an Independent… Orthocell
Media, Video 22 Nov 2023 ABC News | Tennis elbow treatment trial successes offer hope for sufferers wary of surgery This week, Orthocell was featured in a national news story (television, radio, online) about OrthoATI™ on ABC News. Orthocell
Company News 14 Nov 2023 Positive clinical results for OrthoATI™ Orthocell has today released positive results from our clinical study comparing OrthoATI™ to surgery for the treatment of severe chronic… Orthocell
